VENN STRATEGIES, LLC

Lobbying for ELI LILLY AND COMPANY · Pharmaceutical company

Filing 4th Quarter - Amendment

4th Quarter (Oct 1 - Dec 31) 2019 · District of Columbia · House · Senate · $30,000.00 income · posted Jul 6, 2026

Lobbying activity 1

Health Issues

General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation and innovation policies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.